A new case report was published on July 3, 2026 in the journal Frontiers in Surgery. The publication is titled "Anterior cervical osteophyte-related dysphagia in a long-term growth hormone user: a case report." This publication is indexed under PubMed ID 42465868. The case report concerns a long-term user of growth hormone, as stated in its title. No findings, outcomes, or conclusions from the report were provided beyond the title and publication details. Sermorelin remains classified as an unapproved research compound and is referenced here in connection with growth hormone related research literature. This brief reports only the fact that the publication exists, its title, its journal, and its publication date, as provided. No efficacy, safety conclusions, or causal relationships are stated or implied beyond what is listed in the publication title itself. Readers interested in the broader context of sermorelin can consult the compound overview for additional background information.
Case Report on GH User Published; Sermorelin Noted as Research Compound
See the full sermorelin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42465868/